This bill amends the duties and reporting requirements of the Therapeutic Cannabis Medical Oversight Board. It mandates that the board conduct a biennial review of medical and scientific evidence related to both currently approved and additional qualifying conditions for therapeutic cannabis use. This change emphasizes the importance of regularly updating the board's understanding of relevant medical research. Additionally, the bill requires that the board's annual report, due by January 1 each year, includes citations to the medical and scientific evidence reviewed by the board concerning these conditions. This aims to enhance transparency and accountability in the board's findings and recommendations. The act will take effect 60 days after its passage.

Statutes affected:
Introduced: 126-X:12
As Amended by the Senate: 126-X:12
SB400 text: 126-X:12